TransMedics Group, Inc.
TMDX
$125.74
-$2.76-2.15%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 71.66M | 48.95M | 35.46M | 32.64M | 3.00M |
| Total Depreciation and Amortization | 23.73M | 21.59M | 19.76M | 17.68M | 14.40M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 41.18M | 40.15M | 38.58M | 31.85M | 55.34M |
| Change in Net Operating Assets | -21.30M | -61.30M | -45.00M | -44.73M | -49.02M |
| Cash from Operations | 115.27M | 49.38M | 48.80M | 37.44M | 23.72M |
| Capital Expenditure | -97.92M | -112.61M | -129.74M | -157.96M | -217.48M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 441.00K | 441.00K | 441.00K | 441.00K | -14.89M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 0.00 | -27.21M |
| Cash from Investing | -97.48M | -112.17M | -129.30M | -157.52M | -259.58M |
| Total Debt Issued | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Repaid | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Common Stock | 19.17M | 22.72M | 22.87M | 22.61M | 16.27M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Financing | 19.17M | 22.72M | 22.87M | 22.61M | 16.27M |
| Foreign Exchange rate Adjustments | 866.00K | -5.00K | -536.00K | 443.00K | -120.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 37.82M | -40.07M | -58.16M | -97.02M | -219.71M |